Skip to main content
Erschienen in: Investigational New Drugs 3/2016

12.03.2016 | PRECLINICAL STUDIES

Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs

verfasst von: Jessica J. Field, Arun Kanakkanthara, Darby G. Brooke, Saptarshi Sinha, Sushila D. Pillai, William A. Denny, Alison J. Butt, John H. Miller

Erschienen in: Investigational New Drugs | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Summary

The avocado toxin (+)-R-persin (persin) is active at low micromolar concentrations against breast cancer cells and synergizes with the estrogen receptor modulator 4-hydroxytamoxifen. Previous studies in the estrogen receptor-positive breast cancer cell line MCF-7 indicate that persin acts as a microtubule-stabilizing agent. In the present study, we further characterize the properties of persin and several new synthetic analogues in human ovarian cancer cells. Persin and tetrahydropersin cause G2M cell cycle arrest and increase intracellular microtubule polymerization. One analog (4-nitrophenyl)-deshydroxypersin prevents cell proliferation and blocks cells in G1 of the cell cycle rather than G2M, suggesting an additional mode of action of these compounds independent of microtubules. Persin can synergize with other microtubule-stabilizing agents, and is active against cancer cells that overexpress the P-glycoprotein drug efflux pump. Evidence from Flutax-1 competition experiments suggests that while the persin binding site on β-tubulin overlaps the classical taxoid site where paclitaxel and epothilone bind, persin retains activity in cell lines with single amino acid mutations that affect these other taxoid site ligands. This implies the existence of a unique binding location for persin at the taxoid site.
Literatur
1.
Zurück zum Zitat Chang C-F, Isogai A, Kamikado T, Murakoshi S, Sakurai A, Tamura S (1975) Isolation and structure elucidation of growth inhibitors for silkworm larvae from avocado leaves. Agric Biol Chem 39:1167–1168 Chang C-F, Isogai A, Kamikado T, Murakoshi S, Sakurai A, Tamura S (1975) Isolation and structure elucidation of growth inhibitors for silkworm larvae from avocado leaves. Agric Biol Chem 39:1167–1168
2.
Zurück zum Zitat Oelrichs PB, JNg JC, Seawright AA, Ward W, Schäffeler L, MacLeod JK (1995) Isolation and identification of a compound from avocado (Persea americana) leaves which causes necrosis of the acinar epithelium of the lactating mammary gland and the myocardium. Nat Toxins 3:344–349CrossRefPubMed Oelrichs PB, JNg JC, Seawright AA, Ward W, Schäffeler L, MacLeod JK (1995) Isolation and identification of a compound from avocado (Persea americana) leaves which causes necrosis of the acinar epithelium of the lactating mammary gland and the myocardium. Nat Toxins 3:344–349CrossRefPubMed
3.
Zurück zum Zitat MacLeod JK, Schäffeler L (1995) A short enantioselective synthesis of a biologically active compound from Persea americana. J Nat Prod 58:1270–1273CrossRef MacLeod JK, Schäffeler L (1995) A short enantioselective synthesis of a biologically active compound from Persea americana. J Nat Prod 58:1270–1273CrossRef
4.
Zurück zum Zitat Prusky D, Keen NT, Sims JJ, Midland SL (1982) Possible involvement of an antifungal diene in the latency of Colletotrichum gloeosporioides on unripe avocado fruits. Phytopathology 72:1578–1582CrossRef Prusky D, Keen NT, Sims JJ, Midland SL (1982) Possible involvement of an antifungal diene in the latency of Colletotrichum gloeosporioides on unripe avocado fruits. Phytopathology 72:1578–1582CrossRef
5.
Zurück zum Zitat Rodriguez-Saona C, Millar JG, Maynard DF, Trumble JT (1998) Novel antifeedant and insecticidal compounds from avocado idioblast cell oil. J Chem Ecol 24:867–889CrossRef Rodriguez-Saona C, Millar JG, Maynard DF, Trumble JT (1998) Novel antifeedant and insecticidal compounds from avocado idioblast cell oil. J Chem Ecol 24:867–889CrossRef
6.
Zurück zum Zitat Carman RM, Duffield AR, Handley PN, Karoli T (2000) 2-Hydroxy-4-oxohenicosan-1-yl acetate. Its presence in avocado and its simple chemistry. Aust J Chem 53:191–194CrossRef Carman RM, Duffield AR, Handley PN, Karoli T (2000) 2-Hydroxy-4-oxohenicosan-1-yl acetate. Its presence in avocado and its simple chemistry. Aust J Chem 53:191–194CrossRef
7.
Zurück zum Zitat Kingsbury JM (1964) Poisonous Plants of the United States and Canada. Prentice-Hall, Inc., Englewood Cliffs, 124 Kingsbury JM (1964) Poisonous Plants of the United States and Canada. Prentice-Hall, Inc., Englewood Cliffs, 124
8.
Zurück zum Zitat Menéndez JA, Barbacid MD, Montero S, Sevilla E, Escrich E, Solanas M, Cortes-Funes H, Colomer R (2001) Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 37:402–413CrossRefPubMed Menéndez JA, Barbacid MD, Montero S, Sevilla E, Escrich E, Solanas M, Cortes-Funes H, Colomer R (2001) Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 37:402–413CrossRefPubMed
9.
Zurück zum Zitat Butt AJ, Roberts CG, Seawright AA, Oelrichs PB, MacLeod JK, Liaw TYE, Kavallaris M, Somers-Edgar TJ, Lehrbach GM, Watts CK, Sutherland RL (2006) A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5:2300–2309CrossRefPubMed Butt AJ, Roberts CG, Seawright AA, Oelrichs PB, MacLeod JK, Liaw TYE, Kavallaris M, Somers-Edgar TJ, Lehrbach GM, Watts CK, Sutherland RL (2006) A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5:2300–2309CrossRefPubMed
10.
Zurück zum Zitat Roberts CG, Gurisik E, Biden TJ, Sutherland RL, Butt AJ (2007) Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism. Mol Cancer Ther 6:2777–2785CrossRefPubMed Roberts CG, Gurisik E, Biden TJ, Sutherland RL, Butt AJ (2007) Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism. Mol Cancer Ther 6:2777–2785CrossRefPubMed
11.
Zurück zum Zitat McCloy RA, Shelley EJ, Roberts CG, Boslem E, Biden TJ, Nicholson RI, Gee JM, Sutherland RL, Musgrove EA, Burgess A, Butt AJ (2013) Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells. Brit J Cancer 109:3034–3041CrossRefPubMedPubMedCentral McCloy RA, Shelley EJ, Roberts CG, Boslem E, Biden TJ, Nicholson RI, Gee JM, Sutherland RL, Musgrove EA, Burgess A, Butt AJ (2013) Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells. Brit J Cancer 109:3034–3041CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Bonilla-Porras AR, Salazar-Ospina A, Jimenez-Del-Rio M, Pereañez-Jimenez A, Velez-Pardo C (2014) Pro-apoptotic effect of Persea americana var. Hass (avocado) on Jurkat lymphoblastic leukemia cells. Pharm Biol 52:458–465CrossRef Bonilla-Porras AR, Salazar-Ospina A, Jimenez-Del-Rio M, Pereañez-Jimenez A, Velez-Pardo C (2014) Pro-apoptotic effect of Persea americana var. Hass (avocado) on Jurkat lymphoblastic leukemia cells. Pharm Biol 52:458–465CrossRef
13.
Zurück zum Zitat Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265CrossRefPubMed Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265CrossRefPubMed
14.
Zurück zum Zitat Haldar S, Chintapalli J, Croce CM (1996) Taxol induces Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56:1253–1255PubMed Haldar S, Chintapalli J, Croce CM (1996) Taxol induces Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56:1253–1255PubMed
15.
Zurück zum Zitat Kenny FS, Pinder SE, Ellis IO, Gee JM, Nicholson RL, Bryce RP, Robertson JF (2000) Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 85:643–648CrossRefPubMed Kenny FS, Pinder SE, Ellis IO, Gee JM, Nicholson RL, Bryce RP, Robertson JF (2000) Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 85:643–648CrossRefPubMed
16.
Zurück zum Zitat Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3:287–296CrossRefPubMed Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3:287–296CrossRefPubMed
17.
Zurück zum Zitat Ding H, Chin YW, Kinghorn AD, D'Ambrosio SM (2007) Chemopreventive characteristics of avocado fruit. Semin Cancer Biol 17:386–394CrossRefPubMed Ding H, Chin YW, Kinghorn AD, D'Ambrosio SM (2007) Chemopreventive characteristics of avocado fruit. Semin Cancer Biol 17:386–394CrossRefPubMed
18.
Zurück zum Zitat Ding H, Han C, Guo D, Chin YW, Ding Y, Kinghorn AD, D'Ambrosio SM (2009) Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism. Nutr Cancer 61:348–356CrossRefPubMed Ding H, Han C, Guo D, Chin YW, Ding Y, Kinghorn AD, D'Ambrosio SM (2009) Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism. Nutr Cancer 61:348–356CrossRefPubMed
19.
Zurück zum Zitat Paul R, Kulkarni P, Ganesh N (2011) Avocado fruit (Persea americana Mill) exhibits chemo-protective potentiality against cyclophosphamide induced genotoxicity in human lymphocyte culture. J Exp Ther Oncol 9:221–230PubMed Paul R, Kulkarni P, Ganesh N (2011) Avocado fruit (Persea americana Mill) exhibits chemo-protective potentiality against cyclophosphamide induced genotoxicity in human lymphocyte culture. J Exp Ther Oncol 9:221–230PubMed
20.
Zurück zum Zitat Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221–233CrossRefPubMed Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221–233CrossRefPubMed
21.
Zurück zum Zitat Rodriguez-Saona C, Millar JG, Trumble JT (1998) Isolation, identification, and biological activity of isopersin, a new compound from avocado idioblast oil cells. J Nat Prod 61:1168–1170CrossRefPubMed Rodriguez-Saona C, Millar JG, Trumble JT (1998) Isolation, identification, and biological activity of isopersin, a new compound from avocado idioblast oil cells. J Nat Prod 61:1168–1170CrossRefPubMed
22.
Zurück zum Zitat Brooke DG, Shelley EJ, Roberts CG, Denny WA, Sutherland RL, Butt AJ (2011) Synthesis and in vitro evaluation of analogues of avocado-produced toxin (+)-(R)-persin in human breast cancer cells. Bioorg Med Chem 19:7033–7043CrossRefPubMed Brooke DG, Shelley EJ, Roberts CG, Denny WA, Sutherland RL, Butt AJ (2011) Synthesis and in vitro evaluation of analogues of avocado-produced toxin (+)-(R)-persin in human breast cancer cells. Bioorg Med Chem 19:7033–7043CrossRefPubMed
23.
Zurück zum Zitat Prota AE, Bargsten K, Zurwerra D, Field JJ, Díaz JF, Altmann K-H, Steinmetz MO (2013) Molecular mechanism of action of microtubule-stabilizng agents. Science 339:587–590CrossRefPubMed Prota AE, Bargsten K, Zurwerra D, Field JJ, Díaz JF, Altmann K-H, Steinmetz MO (2013) Molecular mechanism of action of microtubule-stabilizng agents. Science 339:587–590CrossRefPubMed
24.
Zurück zum Zitat Prota AE, Bargsten K, Northcote PT, Marsh M, Altmann K-H, Miller JH, Díaz JF, Steinmetz MO (2014) Structural basis of microtubule stabilization by laulimalide and peloruside A. Angew Chem Int Ed 53:1621–1625CrossRef Prota AE, Bargsten K, Northcote PT, Marsh M, Altmann K-H, Miller JH, Díaz JF, Steinmetz MO (2014) Structural basis of microtubule stabilization by laulimalide and peloruside A. Angew Chem Int Ed 53:1621–1625CrossRef
25.
Zurück zum Zitat West LM, Northcote PT, Battershill CN (2000) Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J Org Chem 65:445–449CrossRefPubMed West LM, Northcote PT, Battershill CN (2000) Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J Org Chem 65:445–449CrossRefPubMed
26.
Zurück zum Zitat Field JJ, Singh AJ, Kanakkanthara A, Halafihi T, Northcote PT, Miller JH (2009) Microtubule-stabilizing activity of zampanolide, a potent macrolide isolated from the Tongan marine sponge Cacospongia mycofijiensis. J Med Chem 52:7328–7332CrossRefPubMed Field JJ, Singh AJ, Kanakkanthara A, Halafihi T, Northcote PT, Miller JH (2009) Microtubule-stabilizing activity of zampanolide, a potent macrolide isolated from the Tongan marine sponge Cacospongia mycofijiensis. J Med Chem 52:7328–7332CrossRefPubMed
27.
Zurück zum Zitat Hood KA, West LM, Northcote PT, Berridge MV, Miller JH, Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine. Apoptosis 6:207−219. Hood KA, West LM, Northcote PT, Berridge MV, Miller JH, Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine. Apoptosis 6:207−219.
28.
Zurück zum Zitat Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JTM, Fojo T, Poruchynsky MS (1997) Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 272:17118–17125CrossRefPubMed Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JTM, Fojo T, Poruchynsky MS (1997) Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 272:17118–17125CrossRefPubMed
29.
Zurück zum Zitat Wilmes A, Bargh K, Kelly C, Northcote PT, Miller JH (2007) Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines. Mol Pharm 4:269–280CrossRefPubMed Wilmes A, Bargh K, Kelly C, Northcote PT, Miller JH (2007) Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines. Mol Pharm 4:269–280CrossRefPubMed
30.
Zurück zum Zitat Wilmes A, O’Sullivan D, Chan A, Chandrahasen C, Paterson I, Northcote PT, La Flamme AC, Miller JH (2011) Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells. Cancer Chemother Pharmacol 68:117–126CrossRefPubMed Wilmes A, O’Sullivan D, Chan A, Chandrahasen C, Paterson I, Northcote PT, La Flamme AC, Miller JH (2011) Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells. Cancer Chemother Pharmacol 68:117–126CrossRefPubMed
31.
Zurück zum Zitat Field JJ, Calvo E, Northcote PT, Miller JH, Altmann K-H, Díaz JF (2013) Methods for studying microtubule binding site interactions: Zampanolide as a covalent binding agent. In Wilson L and Correia JJ (eds) Methods in Cell Biology, Vol 115: Microtubules In Vitro, 2nd Ed, Academic Press, Burlington, Chapter 19, pp. 303−325 Field JJ, Calvo E, Northcote PT, Miller JH, Altmann K-H, Díaz JF (2013) Methods for studying microtubule binding site interactions: Zampanolide as a covalent binding agent. In Wilson L and Correia JJ (eds) Methods in Cell Biology, Vol 115: Microtubules In Vitro, 2nd Ed, Academic Press, Burlington, Chapter 19, pp. 303−325
32.
Zurück zum Zitat Lalande M (1990) A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp Cell Res 186:332–339CrossRefPubMed Lalande M (1990) A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp Cell Res 186:332–339CrossRefPubMed
33.
Zurück zum Zitat Kanakkanthara A, Wilmes A, O'Brate A, Escuin D, Chan A, Gjyrezi A, Crawford J, Rawson P, Kivell B, Northcote PT, Hamel E, Giannakakou P, Miller JH (2011) Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes. Mol Cancer Ther 10:1419–1429CrossRefPubMedPubMedCentral Kanakkanthara A, Wilmes A, O'Brate A, Escuin D, Chan A, Gjyrezi A, Crawford J, Rawson P, Kivell B, Northcote PT, Hamel E, Giannakakou P, Miller JH (2011) Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes. Mol Cancer Ther 10:1419–1429CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Giannakakou P, Gussio R, Nogales E, Downing KH, Zaharevitz D, Bollbuck B, Poy G, Sackett D, Nicolaou KC, Fojo T (2000) A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci U S A 97:2904–2909CrossRefPubMedPubMedCentral Giannakakou P, Gussio R, Nogales E, Downing KH, Zaharevitz D, Bollbuck B, Poy G, Sackett D, Nicolaou KC, Fojo T (2000) A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci U S A 97:2904–2909CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Gaitanos TN, Buey RM, Díaz JF, Northcote PT, Teesdale-Spittle P, Andreu JM, Miller JH (2004) Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug resistant cell lines. Cancer Res 64:5063–5067CrossRefPubMed Gaitanos TN, Buey RM, Díaz JF, Northcote PT, Teesdale-Spittle P, Andreu JM, Miller JH (2004) Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug resistant cell lines. Cancer Res 64:5063–5067CrossRefPubMed
36.
Zurück zum Zitat Ding C, Zhang Y, Chen H, Yang Z, Wild C, Ye N, Ester CD, Xiong A, White MA, Shen Q, Zhou J (2013) Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis. J Med Chem 56:8814–8825CrossRefPubMed Ding C, Zhang Y, Chen H, Yang Z, Wild C, Ye N, Ester CD, Xiong A, White MA, Shen Q, Zhou J (2013) Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis. J Med Chem 56:8814–8825CrossRefPubMed
38.
Zurück zum Zitat Hashimura H, Ueda C, Kawabata J, Kasai T (2001) Acetyl-CoA carboxylase inhibitors from avocado (Persea americana Mill) fruits. Biosci Biotechnol Biochem 65:1656–1658CrossRefPubMed Hashimura H, Ueda C, Kawabata J, Kasai T (2001) Acetyl-CoA carboxylase inhibitors from avocado (Persea americana Mill) fruits. Biosci Biotechnol Biochem 65:1656–1658CrossRefPubMed
39.
Zurück zum Zitat Ferlini C, Cicchillitti L, Raspaglio G, Bartollino S, Cimitan S, Bertucci C, Mozzetti S, Gallo D, Persico M, Fattorusso C, Campiani G, Scambia G (2009) Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res 69:6906–6914CrossRefPubMed Ferlini C, Cicchillitti L, Raspaglio G, Bartollino S, Cimitan S, Bertucci C, Mozzetti S, Gallo D, Persico M, Fattorusso C, Campiani G, Scambia G (2009) Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res 69:6906–6914CrossRefPubMed
40.
Zurück zum Zitat Ferlini C, Raspaglio G, Mozzetti S, Martinelli E, Ferrandina G, Gallo D, Riva A, Bombardelli E, Morazzoni P, Scambia G (2003) Bcl-2 downregulation is a novel mechanism of paclitaxel resistance. P. Am. Assoc Cancer Res 44:1104–1104 Ferlini C, Raspaglio G, Mozzetti S, Martinelli E, Ferrandina G, Gallo D, Riva A, Bombardelli E, Morazzoni P, Scambia G (2003) Bcl-2 downregulation is a novel mechanism of paclitaxel resistance. P. Am. Assoc Cancer Res 44:1104–1104
41.
Zurück zum Zitat Menéndez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E, Cortés-Funes H, Colomer R (2002) Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat 72:203–219CrossRefPubMed Menéndez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E, Cortés-Funes H, Colomer R (2002) Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat 72:203–219CrossRefPubMed
42.
Zurück zum Zitat Kowalski RJ, Giannakakou P, Gunasekera P, Longley RE, Day BW, Hamel E (1997) The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol Pharmacol 52:613–622PubMed Kowalski RJ, Giannakakou P, Gunasekera P, Longley RE, Day BW, Hamel E (1997) The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol Pharmacol 52:613–622PubMed
43.
Zurück zum Zitat He L, Yang C-PH, Horwitz SB (2001) Mutations in β-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol Cancer Ther 1:3–10PubMed He L, Yang C-PH, Horwitz SB (2001) Mutations in β-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol Cancer Ther 1:3–10PubMed
44.
Zurück zum Zitat Martello LA, McDaid HM, Regl DL, Yang CP, Meng D, Pettus TR, Kaufman MD, Arimoto H, Danishefsky SJ, Smith AB 3rd, Horwitz SB (2000) Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin Cancer Res 6:1978–1987PubMed Martello LA, McDaid HM, Regl DL, Yang CP, Meng D, Pettus TR, Kaufman MD, Arimoto H, Danishefsky SJ, Smith AB 3rd, Horwitz SB (2000) Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin Cancer Res 6:1978–1987PubMed
45.
Zurück zum Zitat Giannakakou P (2000) Fojo T (2000) Discodermolide: just another microtubule- stabilizing agent? No! A lesson in synergy. Clin Cancer Res 6:1613–1615PubMed Giannakakou P (2000) Fojo T (2000) Discodermolide: just another microtubule- stabilizing agent? No! A lesson in synergy. Clin Cancer Res 6:1613–1615PubMed
46.
Zurück zum Zitat Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA (2004) Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Cancer Res 64:4957–4964CrossRefPubMed Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA (2004) Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Cancer Res 64:4957–4964CrossRefPubMed
Metadaten
Titel
Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs
verfasst von
Jessica J. Field
Arun Kanakkanthara
Darby G. Brooke
Saptarshi Sinha
Sushila D. Pillai
William A. Denny
Alison J. Butt
John H. Miller
Publikationsdatum
12.03.2016
Verlag
Springer US
Erschienen in
Investigational New Drugs / Ausgabe 3/2016
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI
https://doi.org/10.1007/s10637-016-0341-z

Weitere Artikel der Ausgabe 3/2016

Investigational New Drugs 3/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.